Patent ID: 11911518
Assignee: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A method of treating a pediatric or adolescent subject having Attention Deficit Hyperactivity Disorder (ADHD), comprising:
orally administering a solid, oral pharmaceutical composition comprising a plurality of particles, each of the particles comprising:
a core comprising an effective amount of methylphenidate or a pharmaceutical salt thereof;
a sustained release layer; and
a delayed release layer;

wherein the composition comprising the plurality of particles provides at least a 6 hour lag time during which the composition releases no more than 5% of the total methylphenidate or a pharmaceutical salt thereof followed by a sustained release period with a median Tmax of about 12-16 hours when administered to healthy adults.